treatment of various inflammatory disorders. In this study, we have designed and synthesized new N-alkyl-1′-(substituted sulfonyl)spiro[chromene-2,4′-piperidin]-6-amine-based library as potential and novel 5-LO inhibitors. In vitro results showed that several synthesized compounds exhibited high 5-LO inhibitory activity, in parallel with the inhibition of leukotriene B4 (LTB4) production in the rat basophilic
5-LO
抑制剂可潜在地用于治疗各种炎症性疾病。在这项研究中,我们设计并合成了新的N-烷基-1'-(取代磺酰基)螺[色烯-2,4'-
哌啶]-6-胺库作为潜在的新型 5-LO
抑制剂。体外结果表明,几种合成化合物表现出高 5-LO 抑制活性,同时抑制大鼠嗜碱性白血病 (RBL-1) 细胞中
白三烯 B4 (LTB4) 的产生。在合成的化合物中,选择8l进行体内研究,使用小鼠耳
水肿模型:口服8l(100 mg/kg) 抑制
花生四烯酸诱导的耳
水肿、髓
过氧化物酶 (MPO) 活性和 LTB4 合成。
SAR分析和分子对接研究证明了5-LO与合成化合物8l之间的变构结合模式。